Drug name - Vantrela Er

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9572803 TEVA BRANDED PHARM Abuse resistant drug formulation Sep, 2027

(4 years from now)

US9216176 TEVA BRANDED PHARM Abuse resistant drug formulation Sep, 2027

(4 years from now)

US8445018 TEVA BRANDED PHARM Abuse resistant drug formulation Jul, 2029

(6 years from now)

Drugs and Companies using HYDROCODONE BITARTRATE ingredient

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
15MG TABLET, EXTENDED RELEASE;ORAL Discontinued
30MG TABLET, EXTENDED RELEASE;ORAL Discontinued
45MG TABLET, EXTENDED RELEASE;ORAL Discontinued
60MG TABLET, EXTENDED RELEASE;ORAL Discontinued
90MG TABLET, EXTENDED RELEASE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.